Free Republic

Nicolas Hulscher, MPH@NicHulscher·1hBREAKING STUDY: Nattokinase Breaks Down SPIKE PROTEIN, AMYLOID MICROCLOTS, BLOOD CLOTS, and SHRINKS ARTERIAL PLAQUEWe assembled DECADES of evidence to uncover the powerful MULTI-TARGET EFFECTS of nattokinase:- Degrades spike protein- Breaks down harmful amyloid proteins- Dissolves abnormal amyloid microclots- Breaks down fibrin blood clots- Boosts the body’s natural clot-dissolving system- Shrinks arterial plaque- Lowers blood pressure- Reduces blood-clotting factors and platelet clumpingOur new paper, “Proteolytic Targets and Clinical Benefits of Oral Nattokinase: Spike Protein and Amyloid Degradation, Fibrinolysis, and Cardiovascular Risk Reduction,” was produced through a collaboration between The Wellness Company and the McCullough Foundation.It represents one of...

BREAKTHROUGH: Nattokinase DISSOLVES 84% of amyloid microclots within 2 hours in-vitro — a pathology recently found in 100% of COVID-19 vaccinated individuals tested. This enzyme breaks down BOTH the trigger (spike protein) AND the pathological result (amyloid microclots). ALSO SEE https://x.com/NicHulscher/status/1990480242327118185

New England Patriots defensive lineman Christian Barmore was treated for blood clots over the weekend, the team announced Sunday. Barmore, 25, was treated at Mass General Brigham for the blood clots and there is no timetable for his return, the Patriots announced. “Our principal concern at this time is Christian’s health and wellbeing. Fortunately, Mass General Brigham provides some of the best healthcare in the world. While there is no current timetable for his return, we know Christian is getting tremendous care and we look forward to his full recovery,” the team said in a statement. Barmore was absent from...

Far and away the most common question I get from those who took one of the COVID-19 vaccines is: “how do I get this out of my body.” The mRNA and adenoviral DNA products were rolled out with no idea on how or when the body would ever breakdown the genetic code. The synthetic mRNA carried on lipid nanoparticles appears to be resistant to breakdown by human ribonucleases by design so the product would be long-lasting and produce the protein product of interest for a considerable time period. This would be an advantage for a normal human protein being replaced...